MedTrace Logo

Acute Toxicity After Moderate Hypo-fractionated Intensity Modulated Radiotherapy IMRT or Prostate Cancer

NCT05265364 · Status: ACTIVE_NOT_RECRUITING · Type: OBSERVATIONAL · Enrollment: 50

Last updated 2023-10-18

No results posted yet for this study

Summary

External radiation techniques (EBRT) is considered one of the primary therapies for patients of all risk classifications of prostate cacer . EBRT aims to control tumor growth while keeping acute and late adverse events to a minimum and ensuring biochemical progression-free outcome

Conditions

  • Radiation Toxicity

Interventions

RADIATION

IMRT with SIB

moderate hypofractioation using 2.5gy/fr in prostate cancer patients usig IMRT SIB technique

Sponsors & Collaborators

  • hanan fawzy

    lead OTHER

Principal Investigators

  • hanan fawzy · Mansoura University Hospital

Eligibility

Min Age
40 Years
Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-07-25
Primary Completion
2024-12-12
Completion
2024-12-12

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05265364 on ClinicalTrials.gov